Leon Wang

Leon was appointed Executive Vice-President, Asia Pacific in January 2017 and assumed responsibility for the growth and performance of AstraZeneca’s commercial businesses in all our International markets in April. These markets include China & Hong Kong, Asia Area, Australia & New Zealand as well as Latin America and Brazil, Russia and Eurasia and the Middle East and Africa.

Leon joined AstraZeneca China in 2013 as a Vice-President and became President in 2014. Under his leadership China became AstraZeneca’s second-largest market worldwide. Leon has twenty years of experience in the pharmaceutical industry, including a series of positions of increasing responsibility in marketing and business leadership at Roche where he was a Business Unit Vice-President. He is Council Vice Chairman of the Shanghai Association of Foreign Investment, Executive Committee Member responsible for Pricing of the R&D based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment, Corporate Advisory Board Member of China Europe International Business School and guest lecturer at Shanghai International Studies University. He holds a Bachelor of Arts from Shanghai International Studies University and an EMBA from China Europe International Business School.